The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2018

Filed:

Sep. 06, 2013
Applicant:

The Trustees of Columbia University IN the City of New York, New York, NY (US);

Inventors:

Donald W. Landry, New York, NY (US);

Owen O'Connor, Scarsdale, NY (US);

Shi-Xian Deng, White Plains, NY (US);

Matko Kalac, New York, NY (US);

Kristen Alison Rinderspacher, Bronx, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/42 (2006.01); A61K 31/47 (2006.01); C07D 215/40 (2006.01); A61K 31/4709 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 215/40 (2013.01); A61K 31/47 (2013.01); A61K 31/4709 (2013.01); C07D 409/12 (2013.01);
Abstract

The present invention relates to the NQBS class of molecules. It is based, at least in part, on the discovery that a representative group of compounds have been observed to inhibit nuclear translocation of NF-κB subunits. Without being bound by any particular theory, this inhibition of nuclear translocation may be mediated by either (i) binding of the NQBS or related compound to the C-terminus of the RHD, which specifically mediates the nuclear internalization; or (ii) NQBS-mediated stabilization of the dimer/IκB complex, disallowing dissociation of the active NF-κB monomers, and thus, inhibiting the generation of the subunits necessary to enter the nucleus. The NQBS class of molecules, and related molecules, may be used in therapeutic applications where inhibition of NF-κB translocation is beneficial, including but not limited to the treatment of cancer, autoimmune disorders, and inflammatory states.


Find Patent Forward Citations

Loading…